Cincinnati, OH — Procter & Gamble Company proudly announces the addition of Ashley McEvoy to its board of directors, effective December 12. McEvoy, former worldwide chairman of MedTech at Johnson & Johnson, brings three decades of healthcare expertise, enhancing P&G’s commitment to innovation and consumer-centric growth.
During her tenure at Johnson & Johnson, McEvoy led the $27 billion medical devices segment, establishing it as the world’s second-largest in the industry. Her transformative leadership drove the development of integrated, digitized solutions, including pioneering efforts in telehealth, robotics, and digital surgery. McEvoy played a pivotal role in over $20 billion worth of M&A activity, diversifying and expanding the company’s portfolio.
With diverse roles at Johnson & Johnson, from group chairman for consumer medical devices to worldwide president for Ethicon products, McEvoy brings a wealth of experience in management, marketing, and brand roles in consumer healthcare.
Jon Moeller, P&G’s Chairman, President, and CEO, expressed excitement about McEvoy’s appointment, stating, «Ashley’s transformative leadership, innovation track record, and consumer-centric experience will be a valuable asset to P&G. Her expertise enhances our Board’s capability as we enhance lives globally.»
This strategic addition aligns with Procter & Gamble’s ongoing efforts to strengthen market position and consumer offerings. Earlier this month, P&G announced a strategic restructuring, anticipating charges of up to $2.5 billion over two fiscal years. Ashley McEvoy’s appointment underscores P&G’s commitment to navigating these changes with seasoned leadership, focusing on driving innovation in the consumer goods sector. Explore the impact of Ashley McEvoy’s expertise as P&G continues to evolve and innovate in response to dynamic market shifts.
